T1 MOLECULAR PHARMACOLOGY AND DRUG DISCOVERY
- Identification and optimization of a potent and highly selective D3 dopamine receptor agonist
- Abuse-related effects of synthetic cathinones:importance of DAT/SERT relationships
- Cell-type specific examination of central amygdala dopamine receptor 2 expressing neurons as a translational target for pharmacological enhancement of extinction
- Diazepam reduces synaptic GABA type areceptor availability via multiple trafficking mechanisms
- A novel GPCR mediates pancreatic cancer associated fibroblast-cancer cell interaction
- Targeting androgen receptor and trail:a novel treatment paradigm for breast cancer
- Studies on the mechanism of SIRT1/AMPK signaling pathway between hepatocytes and hepatic stellate cells
- Research progress of TREM2 in Alzheimer disease
- TRPA1 channel mediates organophosphate-induced delayed neuropathy
- Cytoplasmic translocation of Cx32 mediates cisplatin resistance in ovarian cancer cells
- Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo
- Gecko crude peptides inhibit migration and lymphangiogenesis by down regulating the expression of VEGF-C in human hepatocellular carcinoma cells and human lymphatic endothelial cells
- Regulatory effects of GRK2 on GPCRs and possible use as a drug target
- Selective targeting p53WTlung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA
- Inhibition of cervical cancer cell proliferation and cervical tumorigenicity caused by farnesoid X receptor activation or over-expression is related to CDKN2A-p14ARF-MDM2-p53 pathway
- Inhibition of miR-873 provides therapeutic benefit in lipopolysaccharide-induced Parkinson disease animal model
- PD-1/PD-L1 checkpoint blockade in immune-antitumortherapy:advances and perspectives
- Regulation of nitric oxide donor JS-K on tumor energy metabolism in H22 tumor-bearing mice
- DL0410,a candidate for anti-Alzheimer disease with multiple targets in multiple pathways
- Saikosaponin-b regulates the proliferation and apoptosis of HepG2 cells by targeting the MACC1/c-Met/Akt signaling pathway
- Insulin-like growth factor-binding protein-3 inhibits IGF-1-induced proliferation of human hepatocellular carcinoma cells
- Restoration of E-cadherin by compound 8J protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell death
- Protective role of brain CYP2J in diverse Parkinson disease animal models
- Combination of carboxyamidotriazole and 1-Methyl-L-tryptophan has synergistic inhibtory effects on programmed death 1 expression
- A novel anti-inflammatory and immunomodulatory drug CP-25 alleviated collagen induced arthritis by down-regulating BAFF-NF-κ B signaling pathway
- Development of an XBP1 agonist,HLJ2,as a potential therapeutic agent for ulcerative colitis
- Gprotein coupled receptors signaling pathways implicate in inflammatory and immune response of rheumatoid arthritis
- Non-junctional Cx32 mediates anti-apoptotic and pro-tumor effects via epidermal growth factor receptor in human cervical cancer cells
- Drug repurposing of histone deacetylase inhibitors that alleviate neutrophilic inflammation in acute lung injury and idiopathic pulmonary fibrosis viainhibiting leukotriene a4 hydrolase and blocking LTB4 biosynthesis
- Effects of methionine enkephalin on immune enhancement by reducing myeloid derived suppressor cells and reprogramming liver metabolism in colon cancer mice
- MicroRNA-10a promotes granulosa cells tumor development
- Estrogen weakens muscle endurance via estrogen receptor-MAPK mediated orosomucoid suppression
- Cellular and molecular perspectives of macrophage in rheumatoid arthritis
- PID1,a new tumor-promoting gene in insulin resistance mediated acceleration of hepatocellular carcinoma development and progression
- Effects of immunoglobulin D on expression of IgD receptor and protein tyrosine kinase signaling in human CD4+T cells
- Improved anti-tumor efficacy and pharmacokinetics of bufalin via PEGylated liposomes
- Involvement of PPARs in the regulation of brain CYP2D by growth hormone
- Discovery of a small-molecule bromodomain-containing protein 4 inhibitor that induces AMP-activated protein kinase-modulated autophagy-associated cell death in breast cancer
- A small-molecule activator of ULK1 that induces cytoprotective autophagy for Parkinson disease treatment
- Functionally diverse ligands modulate different activation states of the formyl peptide receptor 2,a Gprotein-coupled receptor
- CP-25 inhibits the functions of activated human B cells through regulating BAFF-TRAF2-NF-κ B and TNF-alpha-TRAF2-NF-κ B signaling
- SOD mimicAEOL-10150 improve lifespan and delay brain aging via inhibition of senescence-associated secretory phenotype in SAMR1 strain
- Protective action of aspirin and its against endothelial Nlrp3 inflammasome activation in response to LPS stimuli